Imodium AD

Manufacturer: Lil' Drug Store Products, Inc.
Effective date: 2017-12-01
Label type: HUMAN OTC DRUG LABEL
Version: 3
Source: legacy-cache
Hydrated at: 2026-08-02 01:09:25

Label at a glance#

ProductImodium AD

Active ingredientLoperamide Hydrochloride

Label structure11 sections

Dosage and administration

drink plenty of clear fluids to help prevent dehydration caused by diarrhea find right dose on chart. If possible, use weight to dose; otherwise, use age. adults and children 12 years and over 2 caplets after the first loose stool; 1 caplet after each subsequent loose stool; but no more than 4 caplets in 24 hours children 9-11 years (60-95 lbs) 1 caplet after the first loose stool; 1/2 caplet after each subsequent...

Storage and handling

each caplet contains: calcium 10 mg store between 20-25°C (68-77°F) do not use if carton or pouch is open or torn see bottom panel for lot number and expiration date

Contacts and useful links#

PhonePoison Help1-800-222-1222

PhoneLabel contact1-877-895-3665

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient (in each caplet)

OTC - ACTIVE INGREDIENT SECTION

Loperamide HCl 2 mg

Purpose

OTC - PURPOSE SECTION

Anti-diarrheal

Use

INDICATIONS & USAGE SECTION

controls symptoms of diarrhea, including Travelers' Diarrhea

Warnings

WARNINGS SECTION

Allergy alert

SPL UNCLASSIFIED SECTION

Do not use if you have ever had a rash or other allergic reaction to loperamide HCl

OTC - DO NOT USE SECTION

Do not use if you have bloody or black stool

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

fever
mucus in the stool
a history of liver disease

OTC - ASK DOCTOR/PHARMACIST SECTION

Ask a doctor or pharmacist before use if you are taking antibiotics

OTC - WHEN USING SECTION

When using this product tiredness, drowsiness or dizziness may occur. Be careful when driving or operating machinery.

Stop use and ask a doctor if

OTC - STOP USE SECTION

symptoms get worse
diarrhea lasts for more than 2 days
you get abdominal swelling or bulging. These may be signs of a serious condition.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

Directions

DOSAGE & ADMINISTRATION SECTION

drink plenty of clear fluids to help prevent dehydration caused by diarrhea
find right dose on chart. If possible, use weight to dose; otherwise, use age.

adults and children 12 years and over	2 caplets after the first loose stool; 1 caplet after each subsequent loose stool; but no more than 4 caplets in 24 hours
children 9-11 years (60-95 lbs)	1 caplet after the first loose stool; 1/2 caplet after each subsequent loose stool; but no more than 3 caplets in 24 hours
children 6-8 years (48-59 lbs)	1 caplet after the first loose stool; 1/2 caplet after each subsequent loose stool; but no more than 2 caplets in 24 hours
children under 6 years (up to 47 lbs)	ask a doctor

Other information

STORAGE AND HANDLING SECTION

each caplet contains: calcium 10 mg
store between 20-25°C (68-77°F)
do not use if carton or pouch is open or torn
see bottom panel for lot number and expiration date

Inactive ingredients

INACTIVE INGREDIENT SECTION

colloidal silicon dioxide, dibasic calcium phosphate dihydrate, D&C yellow no.10 aluminum lake, FD&C blue no.1 aluminum lake, magnesium stearate, microcrystalline cellulose

Questions or comments?

OTC - QUESTIONS SECTION

call 1-877-895-3665

SPL UNCLASSIFIED SECTION

Repackaged and distributed with permission of manufacturer by:
Lil' Drug Store Products, Inc.
1201 Continental Place NE, Cedar Rapids, IA 52402

PRINCIPAL DISPLAY PANEL - 2 caplet carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Imodium^®
A-D
Loperamide HCl, 2 mg
Anti-Diarrheal

Anti-Diarrheal

Controls the symptoms
of diarrhea

2 CAPLETS

Lil'
Drug Store^®

Principal Display Panel - 2 caplet carton

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Loperamide Hydrochloride	ACTIVE INGREDIENT	77TI35393C	2
Loperamide	ACTIVE MOIETY	6X9OC3H4II	2
aluminum oxide	INACTIVE INGREDIENT	LMI26O6933	2
calcium phosphate, dibasic, dihydrate	INACTIVE INGREDIENT	O7TSZ97GEP	2
cellulose, microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	2
D&C yellow no. 10	INACTIVE INGREDIENT	35SW5USQ3G	2
FD&C blue no. 1	INACTIVE INGREDIENT	H3R47K3TBD	2
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	2
silicon dioxide	INACTIVE INGREDIENT	ETJ7Z6XBU4	2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

Imodium AD
Loperamide Hydrochloride
Loperamide
silicon dioxide
dibasic calcium phosphate dihydrate
D&C yellow no. 10
aluminum oxide
FD&C blue no. 1
magnesium stearate
microcrystalline cellulose

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
66715-9720	66715-9720-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
Loperamide Hydrochloride	77TI35393C	ACTIB
silicon dioxide	ETJ7Z6XBU4	IACT
dibasic calcium phosphate dihydrate	O7TSZ97GEP	IACT
D&C yellow no. 10	35SW5USQ3G	IACT
aluminum oxide	LMI26O6933	IACT
FD&C blue no. 1	H3R47K3TBD	IACT
magnesium stearate	70097M6I30	IACT
microcrystalline cellulose	OP1R32D61U	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 4 · 196 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, COATED / ORAL		176 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
D&C yellow no. 10	D&C YELLOW NO. 10	35SW5USQ3G	CONCENTRATE / ORAL	0.03 mg/1ml		Exact identifier — unii candidate 31 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	GRANULE, FOR SOLUTION / ORAL	1.8 mg/120ml		Exact identifier — unii candidate 49 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	CREAM / VAGINAL		51 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
aluminum oxide	ALUMINUM OXIDE	LMI26O6933	TABLET / ORAL	NA		Exact identifier — unii candidate 2 equally ranked IID candidates
FD&C blue no. 1	FD&C BLUE NO. 1	H3R47K3TBD	CAPSULE, DELAYED RELEASE PELLETS / ORAL	0.01 mg		Exact identifier — unii candidate 37 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	SUSPENSION / ORAL		1600 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
D&C yellow no. 10	D&C YELLOW NO. 10	35SW5USQ3G	SUSPENSION, EXTENDED RELEASE / ORAL		1 mg	Exact identifier — unii candidate 31 equally ranked IID candidates
D&C yellow no. 10	D&C YELLOW NO. 10	35SW5USQ3G	POWDER, FOR SOLUTION / ORAL	NA		Exact identifier — unii candidate 31 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	PELLET / ORAL		34 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	INHALANT / ORAL	0.08 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TAMPON / VAGINAL	NA		Exact identifier — unii candidate 49 equally ranked IID candidates
D&C yellow no. 10	D&C YELLOW NO. 10	35SW5USQ3G	TABLET / SUBLINGUAL	0.23 mg		Exact identifier — unii candidate 31 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	FILM, EXTENDED RELEASE / TRANSDERMAL	49 mg		Exact identifier — unii candidate 49 equally ranked IID candidates
calcium phosphate, dibasic, dihydrate	DIBASIC CALCIUM PHOSPHATE DIHYDRATE	O7TSZ97GEP	TABLET, DELAYED RELEASE / ORAL		2834 mg	Exact identifier — unii candidate 10 equally ranked IID candidates
D&C yellow no. 10	D&C YELLOW NO. 10	35SW5USQ3G	POWDER / ORAL		48 mg	Exact identifier — unii candidate 31 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	SUPPOSITORY / RECTAL	14 mg		Exact identifier — unii candidate 49 equally ranked IID candidates
D&C yellow no. 10	D&C YELLOW NO. 10	35SW5USQ3G	TABLET, FILM COATED / ORAL	120 mg		Exact identifier — unii candidate 31 equally ranked IID candidates
FD&C blue no. 1	FD&C BLUE NO. 1	H3R47K3TBD	POWDER, FOR SUSPENSION / ORAL	1 mg/5ml		Exact identifier — unii candidate 37 equally ranked IID candidates
D&C yellow no. 10	D&C YELLOW NO. 10	35SW5USQ3G	SYRUP / ORAL		4 mg	Exact identifier — unii candidate 31 equally ranked IID candidates
FD&C blue no. 1	FD&C BLUE NO. 1	H3R47K3TBD	LIQUID / ORAL	NA		Exact identifier — unii candidate 37 equally ranked IID candidates
FD&C blue no. 1	FD&C BLUE NO. 1	H3R47K3TBD	TABLET, COATED / ORAL	0.52 mg		Exact identifier — unii candidate 37 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TROCHE / ORAL		300 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, FOR SUSPENSION / ORAL		20100 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	POWDER / RESPIRATORY (INHALATION)	NA		Exact identifier — unii candidate 49 equally ranked IID candidates
calcium phosphate, dibasic, dihydrate	DIBASIC CALCIUM PHOSPHATE DIHYDRATE	O7TSZ97GEP	TABLET, COATED / ORAL	488.7 mg		Exact identifier — unii candidate 10 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET / ORAL		6184 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
D&C yellow no. 10	D&C YELLOW NO. 10	35SW5USQ3G	TABLET, EXTENDED RELEASE / ORAL		14 mg	Exact identifier — unii candidate 31 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	LOZENGE / ORAL		420 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	LOZENGE / TRANSMUCOSAL		100 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, FOR SUSPENSION / ORAL		220 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	IMPLANT / INTRAVITREAL	NA		Exact identifier — unii candidate 39 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	POWDER / ORAL		602 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	POWDER, FOR SOLUTION / ORAL		690 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	WAFER / ORAL	66 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
FD&C blue no. 1	FD&C BLUE NO. 1	H3R47K3TBD	CAPSULE, COATED PELLETS / ORAL	NA		Exact identifier — unii candidate 37 equally ranked IID candidates
FD&C blue no. 1	FD&C BLUE NO. 1	H3R47K3TBD	LOTION / TOPICAL	NA		Exact identifier — unii candidate 37 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	RING / VAGINAL		2 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET, FOR SUSPENSION / ORAL		131 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
D&C yellow no. 10	D&C YELLOW NO. 10	35SW5USQ3G	CAPSULE, LIQUID FILLED / ORAL	1.51 mg		Exact identifier — unii candidate 31 equally ranked IID candidates
FD&C blue no. 1	FD&C BLUE NO. 1	H3R47K3TBD	LIQUID / TOPICAL	NA		Exact identifier — unii candidate 37 equally ranked IID candidates
FD&C blue no. 1	FD&C BLUE NO. 1	H3R47K3TBD	SOLUTION / TOPICAL	0.01 %w/w		Exact identifier — unii candidate 37 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET / ORAL		980 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	GRANULE, DELAYED RELEASE / ORAL	3.2 mg		Exact identifier — unii candidate 49 equally ranked IID candidates
FD&C blue no. 1	FD&C BLUE NO. 1	H3R47K3TBD	SOLUTION / ORAL	1.13 mg/15ml		Exact identifier — unii candidate 37 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	GRANULE, FOR SUSPENSION / ORAL		200 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	GEL / NASAL		20 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	DROPS / ORAL	NA		Exact identifier — unii candidate 49 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET / SUBLINGUAL		10 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	CAPSULE, EXTENDED RELEASE / ORAL		1246 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	SYSTEM / TRANSDERMAL		35 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
FD&C blue no. 1	FD&C BLUE NO. 1	H3R47K3TBD	SOLUTION / DENTAL	NA		Exact identifier — unii candidate 37 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, EXTENDED RELEASE / ORAL		5119 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
calcium phosphate, dibasic, dihydrate	DIBASIC CALCIUM PHOSPHATE DIHYDRATE	O7TSZ97GEP	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	258.45 mg		Exact identifier — unii candidate 10 equally ranked IID candidates
D&C yellow no. 10	D&C YELLOW NO. 10	35SW5USQ3G	SOLUTION / RECTAL	NA		Exact identifier — unii candidate 31 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET / ORAL		750 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, FILM COATED / ORAL		992 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET, EXTENDED RELEASE / ORAL		173 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
D&C yellow no. 10	D&C YELLOW NO. 10	35SW5USQ3G	SUPPOSITORY / RECTAL	0.11 mg		Exact identifier — unii candidate 31 equally ranked IID candidates
calcium phosphate, dibasic, dihydrate	DIBASIC CALCIUM PHOSPHATE DIHYDRATE	O7TSZ97GEP	CAPSULE / ORAL	400 mg		Exact identifier — unii candidate 10 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N019860-001	IMODIUM A-D	LOPERAMIDE HYDROCHLORIDE	2MG	TABLET / ORAL		RLD, RS	1989-11-22

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N019860-001	IMODIUM A-D	2MG	TABLET / ORAL	RLD, RS	1989-11-22	`f41ea6bd6efb…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
7ab79c95-c139-439e-bb51-aee7f84766f3			a35cfa4f-c69d-4bd2-95f6-7ebf2c13247b	2017-12-01	Warnings	Exact identifier spl id: 7ab79c95-c139-439e-bb51-aee7f84766f3 spl set id: a35cfa4f-c69d-4bd2-95f6-7ebf2c13247b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.